2005
DOI: 10.1016/s0001-7310(05)73129-x
|View full text |Cite
|
Sign up to set email alerts
|

Queratodermia acuagénica inducida por celecoxib

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
17
0
3

Year Published

2008
2008
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 36 publications
(20 citation statements)
references
References 8 publications
0
17
0
3
Order By: Relevance
“…A search of the English literature using all proposed terms of TAPH identified 24 cases in the dermatological literature which are summarized in table 1[1,2,3, 5,8,9,10,11,12,13,14,15,16,17,18,19]. However, not included are 12 additional cases of TAPH associated with CF which were published in the 1970s by paediatricians, but lack detailed clinical information [20, 21].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…A search of the English literature using all proposed terms of TAPH identified 24 cases in the dermatological literature which are summarized in table 1[1,2,3, 5,8,9,10,11,12,13,14,15,16,17,18,19]. However, not included are 12 additional cases of TAPH associated with CF which were published in the 1970s by paediatricians, but lack detailed clinical information [20, 21].…”
Section: Discussionmentioning
confidence: 99%
“…Complete resolution of symptoms was achieved after withdrawal of the drug in all cases, suggesting a causative role in the pathogenesis [10, 17, 19]. Rofecoxib and celecoxib are selective inhibitors of cyclo- oxygenase-II (COX-II) which is known to increase sodium reabsorption in the kidney.…”
Section: Discussionmentioning
confidence: 99%
“…While a large proportion of cases of AWP have been found in patients with CF, it has also been reported to be associated with marasmus [1] and with certain medications including cyclo-oxygenase 2 (COX-2) inhibitors [14,15,16] and aminoglycoside antibiotics [17]. …”
Section: Introductionmentioning
confidence: 99%
“…The COX-2 protein is known to be expressed in human keratinocytes [19,20]. The inhibition of COX-2 expression may result in sodium retention in epidermal keratinocytes and thus increased water binding capacity [14,15]. It has been suggested that AWP in CF patients may be mediated by subnormal CFTR regulation of cell membrane water channels [3].…”
Section: Introductionmentioning
confidence: 99%
“…Hastalığın patogenezinde epidermal sodyum konsantrasyonundaki artış sonucu, epidermal keratinositlerin su bağlama kapasitesindeki artış suçlanmıştır 7 . Benzer mekanizma ile rofekoksib ve selekoksib gibi ilaçların, koksigenaz 2 enzimini inhibe edip terde elektrolit konsantrasyonunu arttırarak ASA gelişimine yol açtığı düşünülmüştür 7,11,13,14 . Çalışmamızda bir olgumuzda tespit edilen alopesi areata dışında eşlik eden hastalık ve ilaç öyküsü yoktu.…”
unclassified